Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-national, Randomised, DBPC, Phase II Study to Assess the Efficacy and Safety of Three Doses of SLIT Administered as rBet v 1 Tablets Once Daily to Patients Suffering From Birch Pollen Rhinoconjunctivitis

NCT00901914 is registered in ClinicalTrials.gov with Stallergenes Greer as lead sponsor.

NCT NCT00901914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00901914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-national, Randomised, DBPC, Phase II Study to Assess the Efficacy and Safety of Three Doses of SLIT Administered as rBet v 1 Tablets Once Daily to Patients Suffering From Birch Pollen Rhinoconjunctivitis
Lead sponsor
Stallergenes Greer
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2008
Completion date
August 31, 2009
Enrollment
483 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

birch pollen-related rhinoconjunctivitis, rhinitis, allergic, seasonal